share_log

鲁抗医药(600789.SH):腺苷钴胺胶囊获得药品注册证书

Shandong Lukang Pharmaceutical (600789.SH): Adenosylcobalamin Capsules Obtains Pharmaceutical Registration Certificate.

Gelonghui Finance ·  Aug 13 05:15

Shandong Lukang Pharmaceutical (600789.SH) announced that its subsidiary, Shandong Lukang Pharmaceutical Group Sate Co., Ltd., received the Drug Registration Certificate for Adenosylcobalamin Capsules issued by the State Drug Administration. Adenosylcobalamin Capsules are mainly used for the prevention and treatment of vitamin B12 deficiency, megaloblastic anemia, neurological diseases related to malignant anemia, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment